Skip to main content
. 2020 Jul 20;217(8):e20192336. doi: 10.1084/jem.20192336

Figure 5.

Figure 5.

Reliance on TCR for IEL maintenance. (A) Representative plots of peripheral blood samples taken from TCR Cαfl/fl (left plot, control) or UBCCreERT2×TCR Cαfl/fl mice (right plot) 7 d after administration of tamoxifen. The samples were surface stained for CD4 and CD8 and surface stained with one fluorochrome-conjugated antibody to TCRβ, then intracellularly stained with another. Shown are CD4CD8 cells (gray) and CD8+ T cells (black). (B–E) Frequency of surface TCRβ+ within total (surface and intracellular) TCRβ+ CD8αβ IELs (B) or CD8αα IELs (C) and numbers of total CD8αβ IELs (D) and CD8αα IELs (E) in the small intestine of TCR Cαfl/fl (control) and UBCCreERT2×TCR Cαfl/fl (sample) mice. (F) Proposed model for CD8αα IEL establishment. Each symbol in B–E represents an individual mouse. Horizontal lines indicate the mean. Data are pooled from eight independent experiments. *P < 0.05 and ***P < 0.001 (ANOVA with Bonferroni post-test).